|
|||||
       |
Martin Burke (Univ. of Illinois, Urbana) 4 February 2015. Revolution Medicines Inc., a spin-off enterprise based on research in protein chemistry at University of Illinois, is starting up with $45 million in first-round venture funds. The company is founded by Illinois biochemistry professor Martin Burke, and initially financed by Third Rock Ventures, a . . . → Read More: Biochemistry Spin-Off Formed, Gains $45M Funding  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital (National Institutes of Health) 4 February 2015. A biologic therapy for rheumatoid arthritis was shown to work as well as an approved name-brand biologic treatment in a late-stage clinical trial, according to findings released by biotechnology company Amgen. The study found Amgen’s biologic code-named ABP501 performed as well as adalimumab, marketed as Humira . . . → Read More: Biosimilar Shown Effective for Rheumatoid Arthritis Comments are closed Regulations biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals (NIH.gov) 3 February 2015. A new initiative, called iConquerMS, is recruiting 20,000 patients with multiple sclerosis in the U.S. to offer their health data and research ideas to find a cure for the disease. iConquerMS is an undertaking of the Accelerated Cure Project for MS, with the research network segment funded by Patient-Centered . . . → Read More: Multiple Sclerosis Patients to Crowdsource Health Data One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, grant, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, software, university (Research.gov) 3 February 2015. Lysosomal Therapeutics Inc., a biotechnology company developing treatments for inherited neurodegenerative disorders, raised $20 million in its first venture funding round. The Cambridge, Massachusetts enterprise, begun last year, is backed by several venture capital funds and pharmaceutical companies. Lysosomal Therapeutics is based on the research of Dimitri Krainc, a . . . → Read More: Neuro Disease Biotech Raises $20M in Early Funds One comment - (Comments are closed) Finance biomedical, biotechnology, equity, investment, life sciences, pharmaceuticals, preclinical, university, venture capital Sherry Pagoto (Univ. of Massachusetts Medical School) 2 February 2015. A team from University of Massachusetts Medical School and Worcester Polytechnic Institute are creating a smartphone app combined with a cloud-based data store to help people who overeat due to stress control their eating. The system known as the RELAX Application Suite is . . . → Read More: NIH Grant Funding Stress-Obesity Control System One comment - (Comments are closed) Finance, New products behavioral science, biomedical, engineering, grant, health care, medical device, NIH, software, university (National Cancer Institute) 2 February 2015. An experimental engineered antibody for treating lung cancer received a breakthrough designation from the U.S. Food and Drug Administration. Genentech, a biotechnology subsidiary of drug maker Roche, says breakthrough status was granted for its cancer immunotherapy code-named MPDL3280A to treat programmed death-ligand 1 or PD-L1 positive non-small . . . → Read More: Lung Cancer Antibody Given FDA Breakthrough Tag One comment - (Comments are closed) Regulations biomedical, biotechnology, cancer, clinical trials, FDA, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.